List of redirects
Jump to navigation
Jump to search
Showing below up to 50 results in range #51,881 to #51,930.
- TFIIB → Transcription Factor II B
- TFIID → Transcription Factor II D
- TFIIE → Transcription Factor II E
- TFIIF → Transcription Factor II F
- TFIIH → Transcription Factor II H
- TFIIIA → GTF3A
- TFMPP → Trifluoromethylphenylpiperazine
- TFRC gene → TFRC
- TFT → Thyroid function tests
- TFTs → Thyroid function tests
- TG → Triglyceride
- TGEV → Transmissible gastroenteritis virus
- TGF-beta → TGF beta
- TGF-β → TGF beta
- TGF β → Transforming growth factor
- TGFβ → TGF beta
- TGFβ1 → TGF beta
- TGFβ3 → TGF beta
- TH1 → T helper cell
- TH2-cells → T helper cell
- THAIS → Estradiol
- THANK → B-cell activating factor
- THC → Tetrahydrocannabinol
- THCV → Tetrahydrocannabivarin
- THESEE → A Comparison Of Low-Molecular-Weight Heparin With Unfractionated Heparin For Acute Pulmonary Embolism
- THF → Tetrahydrofuran
- THG → Tetrahydrogestrinone
- THINRS → The Home Inr Study
- THOP → Treatment Of Hypertension Based On Home Or Office Blood Pressure
- THRIVE → Thrombin Inhibitor In Venous Thromboembolism
- THUNDER → Taxan With Short Time For Contact For Reduction Of Restenosis In Distal Arteries
- THX → Levothyroxine
- THYROGEN → Thyrotropin alpha
- TIA → Transient ischemic attack
- TIA-1 → TIA1
- TIBBS → Total Ischemic Burden Bisoprolol Study
- TIBC → Total iron-binding capacity
- TIBET → Total Ischemic Burden European Trial
- TICE → Bacillus Calmette-Guérin
- TIGER-PA → Tirofiban Given In The Emergency Room Before Primary Angioplasty
- TIM → Triflusal In Myocardial Infarction
- TIMACS → Timing Of Intervention In Patients With Acute Coronary Syndromes
- TIMBER → Transthoracic Incremental Monophasic Versus Biphasic Defibrillation By Emergency Responders
- TIME → Trial Of Invasive Versus Medical Therapy In The Elderly
- TIME-CHF → Trial Of Intensified Vs Standard Medical Therapy In Elderly Patients With Congestive Heart Failure
- TIMIC → Efficacy Of Immunosuppressive Therapy In Patients With Virus-Negative Inflammatory Cardiomyopathy
- TIMI 1 → Thrombolysis In Myocardial Infarction Trial, Phase I
- TIMI 10B → Tnk-Tissue Plasminogen Activator Compared With Front-Loaded Tissue Plasminogen Activator In Acute Myocardial Infarction
- TIMI 11B → Thrombolysis In Myocardial Ischemia Trial, Phase 11B
- TIMI 16-OPUS → Orbofiban In Patients With Unstable Coronary Syndromes, Thrombolysis In Myocardial Infarction